Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators In Vitro and In Vivo

[1]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[2]  Yeong Shik Kim,et al.  Anti-inflammatory activity of 21 (α, β)-methylmelianodiols, novel compounds from Poncirus trifoliata Rafinesque , 2007 .

[3]  B. Aggarwal,et al.  Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. , 2007, Carcinogenesis.

[4]  Yeong Shik Kim,et al.  Anti-inflammatory activity of 21(alpha, beta)-methylmelianodiols, novel compounds from Poncirus trifoliata Rafinesque. , 2007, European journal of pharmacology.

[5]  L. O’Neill,et al.  Targeting signal transduction as a strategy to treat inflammatory diseases , 2006, Nature Reviews Drug Discovery.

[6]  R. Sun,et al.  Relations of nuclear factor-kappa B activity in the kidney of children with primary nephrotic syndrome to clinical manifestations, pathological types, and urinary protein excretion. , 2005, Chinese medical journal.

[7]  Seaver,et al.  Nitric oxide as a secretory product of mammalian cells , 2004 .

[8]  K. Ahn,et al.  Downregulation of NF-kappaB activation in human keratinocytes by melanogenic inhibitors. , 2003, Journal of dermatological science.

[9]  K. Ahn,et al.  Kojic acid, a potential inhibitor of NF-κB activation in transfectant human HaCaT and SCC-13 cells , 2001, Archives of pharmacal research.

[10]  Yeong Shik Kim,et al.  A cell-based assay system for monitoring NF-kappaB activity in human HaCat transfectant cells. , 2001, Analytical biochemistry.

[11]  M. Nair,et al.  Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  Xianglin Shi,et al.  New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. , 1999, Clinical chemistry.

[13]  K. N. Rajasekharan,et al.  Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. , 1996, Mutation research.

[14]  M. Currie,et al.  Nitric oxide: a key mediator in the early and late phase of carrageenan‐induced rat paw inflammation , 1996, British journal of pharmacology.

[15]  G. Kuttan,et al.  Anti-tumour and antioxidant activity of natural curcuminoids. , 1995, Cancer letters.

[16]  K. Seibert,et al.  Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Martins,et al.  Mouse paw edema. A new model for inflammation? , 1987, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[18]  Yang Mk,et al.  Separation and determination of curcuminoids in Curcuma longa L. and its preparation by HPLC , 1986 .

[19]  D. Y. Zhao,et al.  [Separation and determination of curcuminoids in Curcuma longa L. and its preparation by HPLC]. , 1986, Yao xue xue bao = Acta pharmaceutica Sinica.

[20]  I. Kushner.  THE PHENOMENON OF THE ACUTE PHASE RESPONSE * , 1982, Annals of the New York Academy of Sciences.

[21]  V. Ravindranath,et al.  Metabolism of curcumin--studies with [3H]curcumin. , 1981, Toxicology.